FDA approves first drug for steroid-refractory acute GVHDMay 30, 2019Cellular TherapyPatient & Survivor CareTransplant
Biomarker testing may transform treatment of acute GVHDApril 26, 2019TransplantPatient & Survivor Care
CDC warns against misuse of opioid-prescribing guidelineApril 24, 2019AnemiaPatient & Survivor CareOpioid Resource Center
Quality of life decrement with salvage ASCT is short-livedApril 23, 2019Multiple MyelomaTransplantPatient & Survivor Care
Study highlights lack of data on transgender leukemia patientsApril 19, 2019AMLPatient & Survivor Care
ASCO/ASH Clinical Practice Update: Erythropoiesis-stimulating agentsApril 15, 2019Patient & Survivor Care
CDC clarifies opioid prescribing guidelines in cancer, sickle cell diseaseApril 15, 2019Patient & Survivor CareOpioid Resource CenterAnemiaBusiness of Medicine
Worse survival seen among black patients with MCLMarch 20, 2019Mantle Cell LymphomaPatient & Survivor CareB Cell Lymphoma
KD025 produces durable responses in patients with cGVHDMarch 7, 2019Patient & Survivor CareCellular Therapy
